1. Home
  2. BCYC vs CBNK Comparison

BCYC vs CBNK Comparison

Compare BCYC & CBNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • CBNK
  • Stock Information
  • Founded
  • BCYC 2009
  • CBNK 1974
  • Country
  • BCYC United Kingdom
  • CBNK United States
  • Employees
  • BCYC N/A
  • CBNK N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • CBNK Major Banks
  • Sector
  • BCYC Health Care
  • CBNK Finance
  • Exchange
  • BCYC Nasdaq
  • CBNK Nasdaq
  • Market Cap
  • BCYC 492.1M
  • CBNK 536.4M
  • IPO Year
  • BCYC 2019
  • CBNK 2018
  • Fundamental
  • Price
  • BCYC $7.96
  • CBNK $30.08
  • Analyst Decision
  • BCYC Buy
  • CBNK Hold
  • Analyst Count
  • BCYC 11
  • CBNK 1
  • Target Price
  • BCYC $22.91
  • CBNK $35.00
  • AVG Volume (30 Days)
  • BCYC 303.4K
  • CBNK 50.6K
  • Earning Date
  • BCYC 10-30-2025
  • CBNK 10-27-2025
  • Dividend Yield
  • BCYC N/A
  • CBNK 1.59%
  • EPS Growth
  • BCYC N/A
  • CBNK 11.33
  • EPS
  • BCYC N/A
  • CBNK 2.69
  • Revenue
  • BCYC $19,281,000.00
  • CBNK $205,155,000.00
  • Revenue This Year
  • BCYC N/A
  • CBNK $47.22
  • Revenue Next Year
  • BCYC N/A
  • CBNK $7.72
  • P/E Ratio
  • BCYC N/A
  • CBNK $11.26
  • Revenue Growth
  • BCYC N/A
  • CBNK 30.26
  • 52 Week Low
  • BCYC $6.10
  • CBNK $24.10
  • 52 Week High
  • BCYC $28.67
  • CBNK $36.40
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 58.20
  • CBNK 31.76
  • Support Level
  • BCYC $7.40
  • CBNK $29.54
  • Resistance Level
  • BCYC $8.69
  • CBNK $30.94
  • Average True Range (ATR)
  • BCYC 0.38
  • CBNK 0.85
  • MACD
  • BCYC 0.11
  • CBNK -0.25
  • Stochastic Oscillator
  • BCYC 62.23
  • CBNK 17.70

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About CBNK Capital Bancorp Inc.

Capital Bancorp Inc is a bank holding company. The company through its holdings operates as a commercial-focused community bank that serves businesses, not-for-profit associations, and entrepreneurs throughout the region. The bank operates through four divisions including Commercial Banking, Capital Bank Home Loans, OpenSky, and Windsor Advantage, and also operates in five business segments: commercial banking; mortgage banking; credit cards; government loan servicing; and corporate activities.

Share on Social Networks: